169 related articles for article (PubMed ID: 11032004)
1. [Lowe syndrome(oculocerebrorenal syndrome of Lowe; OCRL)].
Ohno K
Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):489-90. PubMed ID: 11032004
[No Abstract] [Full Text] [Related]
2. [Lowe syndrome].
Endo F; Kawano T
Ryoikibetsu Shokogun Shirizu; 2001; (36):473-6. PubMed ID: 11596441
[No Abstract] [Full Text] [Related]
3. [Investigation and OCRL mutation analysis of a family with oculocerebrorenal syndrome of Lowe].
Shi RM; Bian XH; Li LM; Liu XH
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):366-9. PubMed ID: 24750831
[TBL] [Abstract][Full Text] [Related]
4. Whole-genome sequencing revealed an interstitial deletion encompassing OCRL and SMARCA1 gene in a patient with Lowe syndrome.
Zheng B; Chen Q; Wang C; Zhou W; Chen Y; Ding G; Jia Z; Zhang A; Huang S
Mol Genet Genomic Med; 2019 Sep; 7(9):e876. PubMed ID: 31376231
[TBL] [Abstract][Full Text] [Related]
5. OCRL deficiency impairs endolysosomal function in a humanized mouse model for Lowe syndrome and Dent disease.
Festa BP; Berquez M; Gassama A; Amrein I; Ismail HM; Samardzija M; Staiano L; Luciani A; Grimm C; Nussbaum RL; De Matteis MA; Dorchies OM; Scapozza L; Wolfer DP; Devuyst O
Hum Mol Genet; 2019 Jun; 28(12):1931-1946. PubMed ID: 30590522
[TBL] [Abstract][Full Text] [Related]
6. Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe.
Leahey AM; Charnas LR; Nussbaum RL
Hum Mol Genet; 1993 Apr; 2(4):461-3. PubMed ID: 8504307
[TBL] [Abstract][Full Text] [Related]
7. Oculocerebrorenal syndrome of Lowe (OCRL) controls leukemic T-cell survival by preventing excessive PI(4,5)P
Chen H; Lu C; Tan Y; Weber-Boyvat M; Zheng J; Xu M; Xiao J; Liu S; Tang Z; Lai C; Li M; Olkkonen VM; Yan D; Zhong W
J Biol Chem; 2023 Jun; 299(6):104812. PubMed ID: 37172724
[TBL] [Abstract][Full Text] [Related]
8. Loss of OCRL increases ciliary PI(4,5)P
Prosseda PP; Luo N; Wang B; Alvarado JA; Hu Y; Sun Y
J Cell Sci; 2017 Oct; 130(20):3447-3454. PubMed ID: 28871046
[TBL] [Abstract][Full Text] [Related]
9. OCRL-mutated fibroblasts from patients with Dent-2 disease exhibit INPP5B-independent phenotypic variability relatively to Lowe syndrome cells.
Montjean R; Aoidi R; Desbois P; Rucci J; Trichet M; Salomon R; Rendu J; Fauré J; Lunardi J; Gacon G; Billuart P; Dorseuil O
Hum Mol Genet; 2015 Feb; 24(4):994-1006. PubMed ID: 25305077
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel deletion of the entire OCRL1 gene detected by FISH analysis in a family with Lowe syndrome.
Peverall J; Edkins E; Goldblatt J; Murch A
Clin Genet; 2000 Dec; 58(6):479-82. PubMed ID: 11149618
[TBL] [Abstract][Full Text] [Related]
11. A novel interstitial deletion in Xq25, identified by array-CGH in a patient with Lowe syndrome.
Addis M; Meloni C; Congiu R; Santaniello S; Emma F; Zuffardi O; Ciccone R; Cao A; Melis MA; Cau M
Eur J Med Genet; 2007; 50(1):79-84. PubMed ID: 17142121
[TBL] [Abstract][Full Text] [Related]
12. Role of oculocerebrorenal syndrome of Lowe (OCRL) protein in megakaryocyte maturation, platelet production and functions: a study in patients with Lowe syndrome.
Egot M; Lasne D; Poirault-Chassac S; Mirault T; Pidard D; Dreano E; Elie C; Gandrille S; Marchelli A; Baruch D; Rendu J; Fauré J; Flaujac C; Gratacap MP; Sié P; Gaussem P; Salomon R; Baujat G; Bachelot-Loza C
Br J Haematol; 2021 Mar; 192(5):909-921. PubMed ID: 33528045
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of OCRL gene mutation in a male infant with Lowe syndrome].
Chen S; Zhang X; Chen L; Tian Q; Jiang W
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2014 Apr; 31(2):223-7. PubMed ID: 24711037
[TBL] [Abstract][Full Text] [Related]
14. Lowe syndrome - Case report with a novel mutation in the oculocerebrorenal gene.
Sethi S; Sethi N; Mehta S; Kaur S; Makkar V; Sohal PM
Saudi J Kidney Dis Transpl; 2020; 31(1):285-288. PubMed ID: 32129227
[TBL] [Abstract][Full Text] [Related]
15. Duplication of OCRL and adjacent genes associated with autism but not Lowe syndrome.
Schroer RJ; Beaudet AL; Shinawi M; Sahoo T; Patel A; Sun Q; Skinner C; Stevenson RE
Am J Med Genet A; 2012 Oct; 158A(10):2602-5. PubMed ID: 22965764
[TBL] [Abstract][Full Text] [Related]
16. The protein deficient in Lowe syndrome is a phosphatidylinositol-4,5-bisphosphate 5-phosphatase.
Zhang X; Jefferson AB; Auethavekiat V; Majerus PW
Proc Natl Acad Sci U S A; 1995 May; 92(11):4853-6. PubMed ID: 7761412
[TBL] [Abstract][Full Text] [Related]
17. Functional Characterization and Rescue of a Deep Intronic Mutation in OCRL Gene Responsible for Lowe Syndrome.
Rendu J; Montjean R; Coutton C; Suri M; Chicanne G; Petiot A; Brocard J; Grunwald D; Pietri Rouxel F; Payrastre B; Lunardi J; Dorseuil O; Marty I; Fauré J
Hum Mutat; 2017 Feb; 38(2):152-159. PubMed ID: 27790796
[TBL] [Abstract][Full Text] [Related]
18. Second messengers and Lowe syndrome.
Irvine R
Nat Genet; 1992 Aug; 1(5):315-6. PubMed ID: 1338770
[No Abstract] [Full Text] [Related]
19. A premature termination mutation in a patient with Lowe syndrome without congenital cataracts: dropping the "O" in OCRL.
Pasternack SM; Böckenhauer D; Refke M; Tasic V; Draaken M; Conrad C; Born M; Betz RC; Reutter H; Ludwig M
Klin Padiatr; 2013 Jan; 225(1):29-33. PubMed ID: 22915452
[TBL] [Abstract][Full Text] [Related]
20. [Lowe syndrome].
Nakabayashi H
Nihon Rinsho; 2006 Sep; Suppl 3():468-72. PubMed ID: 17022589
[No Abstract] [Full Text] [Related]
[Next] [New Search]
